CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-09 | JOHNSON JOHN Director | Option exercise | +8,545 | $6.30 | $54K | 21,686 |
| 2025-12-09 | JOHNSON JOHN Director | Sale | −8,545 | $29.98 | $256K | 13,141 |
| 2025-12-09 | JOHNSON JOHN Director | Sale | −13,141 | $29.98 | $394K | 0 |
| 2025-12-09 | JOHNSON JOHN Director | Option exercise · Stock Option (right to purchase) | −8,545 | 0 | ||
| 2025-12-09 | DALE MICHAEL D Chief Executive Officer | Sale | −61,463 | $31.21 | $1.9M | 88,537 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise | +14,248 | $7.04 | $100K | 14,248 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise | +10,860 | $10.95 | $119K | 25,108 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Sale | −14,248 | $30.98 | $441K | 10,860 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Sale | −10,860 | $30.98 | $336K | 0 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise · Employee Stock Option (right to purchase) | −14,248 | 0 | ||
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise · Stock Option (right to purchase) | −10,860 | 32,311 | ||
| 2025-12-09 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −19,517 | $31.21 | $609K | 241,132 |
| 2025-12-09 | Kemp Jens Chief Marketing Officer | Sale | −8,156 | $31.21 | $255K | 46,030 |
| 2025-12-09 | Began Marc A EVP & General Counsel | Sale | −9,278 | $31.21 | $290K | 31,507 |
| 2025-12-09 | THOMAS PAUL Director | Sale | −21,399 | $29.61 | $634K | 13,528 |
| 2025-12-08 | JOHNSON JOHN Director | Sale | −11,802 | $31.26 | $369K | 13,141 |
| 2025-12-08 | JOHNSON JOHN Director | Option exercise | +11,891 | $6.30 | $75K | 25,032 |
| 2025-12-08 | JOHNSON JOHN Director | Sale | −11,891 | $31.22 | $371K | 13,141 |
| 2025-12-08 | JOHNSON JOHN Director | Option exercise · Stock Option (right to purchase) | −11,891 | 8,545 | ||
| 2025-12-08 | Hartley Lindsey Marie CFO | Option exercise | +20,000 | $15.22 | $304K | 40,763 |
Page 6 of 61 · 1,220 trades